iCAD
AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.
About
Technology stack
detected 2026-06-23No comments yet. Be the first to share your take.
What does iCAD do?
iCAD, Inc. is a global medical technology company specializing in AI-powered solutions for cancer detection and therapy. Their ProFound Breast Health Suite offers clinically validated tools for early cancer detection, automated breast density assessment, and personalized short-term risk evaluation, aiming to improve patient outcomes.
How much funding has iCAD raised?
iCAD has raised a total of $38M in funding. The most recent round on record is Direct Offering.
Where is iCAD headquartered?
iCAD is headquartered in Nashua, United States.
When was iCAD founded?
iCAD was founded in 1984.
What industry does iCAD operate in?
iCAD operates in MedTech, HealthTech, AI-Driven Protein Design, Clinical Trials, Genomics, Biotech.
How many employees does iCAD have?
iCAD has approximately 353 people on record.